Hepatitis B and C virus sexual transmission among homosexual men

The American Journal of Gastroenterology
A R OsellaS Sileoni

Abstract

We estimated hepatitis B virus (HBV) and hepatitis C virus (HCV) sexual transmission among homosexual men. Two hundred twenty-eight homosexually active men attending two clinical centers and presenting no risk factors except for sexual exposure were interviewed, and a blood sample was drawn. HBV marker test was performed using enzyme-linked immunosorbent assay (ELISA) and radioimmunoassay, and HCV was tested using ELISA-2 and recombinant immunoblot assay-2. HBV and HCV infection prevalence rates were 34.4% and 12.7%, respectively. Using logistic regression analysis including sexual exposure and controlling for confounders, we found that anal receptive intercourse (odds ratio [OR] = 4.01; 95% confidence interval [CI] = 1.34-11.94), duration of homosexuality (OR = 3.43; 95% CI = 1.29-9.12), insertive anilingus (OR = 2.02; 95% CI = 1.06-3.87), and sexually transmitted diseases (OR = 1.87; 95% CI = 1.00-3.47) were independently associated with the risk of HBV sexual transmission. We did not find any association between sexual behavior and HCV transmission. Sexual behavior is a plausible explanatory factor of HBV sexual transmission among homosexual men. Further evidence is needed to elucidate the occurrence and the efficiency of HC...Continue Reading

References

Jan 1, 1979·Epidemiologic Reviews·D P Francis, J E Maynard
Oct 1, 1977·The Journal of Infectious Diseases·T ShikataY Moritsugu
Oct 1, 1975·Annals of Internal Medicine·W SzmunessG H Block
Dec 1, 1992·Journal of Medical Virology·Y C KoP Y Chang
Nov 1, 1992·European Journal of Epidemiology·E RicchiF Chiodo
May 1, 1992·Digestive Diseases and Sciences·G J KotwalB M Baroudy
Jun 1, 1991·BMJ : British Medical Journal·R S TedderI V Weller
Jan 11, 1992·American Journal of Epidemiology·G R SeageG A Lamb
Jul 28, 1990·BMJ : British Medical Journal·M MelbyeN G Becker
Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K KiyosawaR H Purcell
Mar 2, 1990·JAMA : the Journal of the American Medical Association·M J AlterL A Moyer
Oct 10, 1970·Lancet·J Vahrman
Jul 1, 1982·The Journal of Infectious Diseases·M T SchreederG Reynolds
Apr 1, 1995·Journal of Pediatric Gastroenterology and Nutrition·M J Nowicki, W F Balistreri
Nov 1, 1994·The Journal of Infection·S P BuchbinderM J Alter
Jul 1, 1997·Journal of Hepatology·A R OsellaG Fiore

❮ Previous
Next ❯

Citations

Jan 21, 2000·Australian and New Zealand Journal of Public Health·R WatsonS Thompson
Jan 11, 2000·Clinical Microbiology Reviews·P LeyssenJ Neyts
Feb 8, 2003·Journal of Clinical Microbiology·Thomas BourletBruno Pozzetto
Aug 16, 2002·Sexually Transmitted Infections·M G Brook
Jul 3, 2010·The American Journal of Tropical Medicine and Hygiene·Javier R LamaUNKNOWN Peruvian HIV Sentinel Surveillance Working Group
Dec 9, 2010·International Journal of STD & AIDS·G BrookC Bergin
Oct 9, 2001·International Journal of STD & AIDS·M G Brook, UNKNOWN European Branch of the Internatioanl Union against Sexually Transmitted Infection and the European Office of the World Healt
Aug 15, 2003·Sexually Transmitted Diseases·Catherine DiamondUNKNOWN Seattle Young Men's Survey Team
Mar 6, 2002·Journal of Viral Hepatitis·M I Memon, M A Memon
Jul 17, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rania A Tohme, Scott D Holmberg
Nov 24, 1999·Oral Diseases·K Roy, J Bagg
Oct 7, 2006·Current Opinion in Gastroenterology·A Regev, E R Schiff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.